SCHEMBL4285857

SCHEMBL4285857

CN(C(=O)c1cnccn1)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)nc1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 1/20 0.37
NAPRT Q6XQN6 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GPBAR1 Q8TDU6 3/20 0.34
CYP3A4 P08684 2/20 0.34
ADORA3 P0DMS8 1/20 0.33
MC4R P32245 1/20 0.33
ADRA1A P35348 1/20 0.33
MC3R P41968 1/20 0.33
PSMB11 A5LHX3 1/20 0.33
PSMA7 O14818 1/20 0.33
PSMB1 P20618 1/20 0.33
PSMA1 P25786 1/20 0.33
PSMA2 P25787 1/20 0.33
PSMA3 P25788 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4288801 0.90 HTT (0.39) TSHRHSD17B10KDM4ENPC1RAB9A
SCHEMBL4289698 0.84 ALDH1A1 (0.43) ALDH1A1CYP3A4CYP2D6GRM5CYP1A2
SCHEMBL4286953 0.71 PDE10A (0.42) TSHRALDH1A1CYP3A4CYP1A2
SCHEMBL4285067 0.71 TSHR (0.47) TSHRKDM4ERAB9AALDH1A1CYP3A4
SCHEMBL4289310 0.66 ALDH1A1 (0.37) TSHRHSD17B10KDM4EALDH1A1CYP1A2
SCHEMBL29286714 0.66 ALDH1A1 (0.37) TSHRALDH1A1CYP1A2
SCHEMBL27815941 0.64 PTGER1 (0.40) TSHRHSD17B10KDM4ENPC1RAB9A
SCHEMBL27815920 0.62 ALDH1A1 (0.34) TSHRKDM4EALDH1A1CYP1A2
SCHEMBL31086815 0.62 KDM4E (0.57) TSHRHSD17B10KDM4ENAPRTHCAR2
SCHEMBL2011634 0.62 KDM4E (0.57) TSHRHSD17B10KDM4ENAPRTHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156582-A1 Pyrazole Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-18 US disclosed
EP-1847531-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156582-A1 Pyrazole Compound GSK3B, GSK3A, GSKIP TSHR 2251/4885HSD17B10 688/4885KDM4E 810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.